Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Oxford PharmaGenesis launches its new HealthScience approach

Unveils integrated approach to engaging physicians, patients and policy-makers

- PMLiVE

Building trial engagement through mobile devices

Six steps to integrating a 'bring your own device' approach within your clinical research strategy

- PMLiVE

UK authorities open investigation into GSK

Serious Fraud Office launches probe after international corruption allegations

National Institute for Health and Care Excellence NICE logo

NICE backs reimbursement of Sanofi’s MS drug Lemtrada

Final guidance opens doors for use on NHS in England and Wales

EU flag

EC approves drugs for diabetes and Crohn’s disease

Takeda’s Entyvio and Boehringer/Lilly’s Jardiance get green light

- PMLiVE

New hires for Wave

Med ed agency adds three new team members

- PMLiVE

Healthcare missing from most valuable brand index

Google tops Millward Brown’s list for 2014

- PMLiVE

Kirsti Gjellan swaps Pfizer for Sobi

Takes up role as senior VP manufacturing operations at Swedish Orphan Biovitrum

- PMLiVE

The digital transformation of market research

How technology is bringing new clarity to the patient voice

- PMLiVE

Pfizer abandons AZ takeover bid – for now

Deadline for deal passes after four rejected offers

Roche - Basel

CHMP turns down Avastin for brain cancer

Roche set to be denied expanded use for oncology drug in Europe

- PMLiVE

CHMP backs European approval for six new medicines

Recommends drugs by PTC Therapeutics, Roche, Biogen Idec, Octapharma, Alcon and Veloxis Pharma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links